Sangui Biotech International Inc SGBI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.02
- Bid/Ask
- $0.00 / $0.00
- Market Cap
- $314,852.76
- Volume/Avg
- 200,000 / 16,663
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Sangui Biotech International Inc develops pharmaceutical, medical and cosmetic products, through its subsidiary. The company develops oxygen carriers for providing oxygen transport in humans due to acute or chronic lack of oxygen and in the case of chronic wounds. It has also developed external applications of oxygen transporters in the form of sprays for healing chronic wounds and gels and emulsions for the regeneration of the skin. The products offered are artificial oxygen carriers; Chitoskin wound pads; and haemoglobin-based wound spray technology sold under the brand name Granulox. It derives revenue from licensing fees on sales of its wound spray product.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- —
- Website
- http://www.sanguibiotech.com
Valuation
|
Metric
|
SGBI
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
SGBI
|
|---|---|
Quick Ratio | 0.03 |
Current Ratio | 0.04 |
Interest Coverage | −5.11 |
Quick Ratio
SGBI
Profitability
|
Metric
|
SGBI
|
|---|---|
Return on Assets (Normalized) | −112.16% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
SGBI
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Kdvblcznv | Rjqt | $82.5 Bil | |||
| Merck KGaA ADR
MKKGY
| Fjpdhpllz | Dfnxkq | $73.2 Bil | |||
| Haleon PLC ADR
HLN
| Jkphqph | Kyjs | $41.0 Bil | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| Pvbpzyqm | Xpnf | $19.2 Bil | |||
| Viatris Inc
VTRS
| Pqyjsvkf | Sdzp | $14.0 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Gnfflltky | Dndct | $13.6 Bil | |||
| Catalent Inc
CTLT
| Hyvhqwzw | Yzxhlf | $10.6 Bil | |||
| Perrigo Co PLC
PRGO
| Zkwkpxdb | Jqwbm | $3.8 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Zgwqwcn | Mdvsc | $3.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Hkflvdyj | Hhw | $3.0 Bil |